David Dickens
@davidsdickens.bsky.social
Principle Investigator. Research interests include membrane transporters, psychopharmacology, genetics & the blood-brain barrier (BBB)
More details www.findaphd.com/phds/project... bit.ly/DiMeNPhDDead...: Dec 4, 2025 #PhD #Neuroscience #DrugSafety. Fully funded for UK students only
MRC DiMeN Doctoral Training Partnership: Towards Mitigating Severe Neurotoxicity in T-cell Immunotherapy at University of Liverpool on FindAPhD.com
PhD Project - MRC DiMeN Doctoral Training Partnership: Towards Mitigating Severe Neurotoxicity in T-cell Immunotherapy at University of Liverpool, listed on FindAPhD.com
www.findaphd.com
October 24, 2025 at 9:38 AM
More details www.findaphd.com/phds/project... bit.ly/DiMeNPhDDead...: Dec 4, 2025 #PhD #Neuroscience #DrugSafety. Fully funded for UK students only
Shout out to Josephine Pedder and Andrew Sellin for presenting at the meeting and congratulations to Jo for winning the Best PhD student presentation award!
July 21, 2025 at 9:05 AM
Shout out to Josephine Pedder and Andrew Sellin for presenting at the meeting and congratulations to Jo for winning the Best PhD student presentation award!
The British Association for Psychopharmacology summer meeting showcased cutting edge psychopharmacology research and was an excellent meeting!
July 2, 2025 at 6:24 PM
The British Association for Psychopharmacology summer meeting showcased cutting edge psychopharmacology research and was an excellent meeting!
Many thanks to Paulina Kolasinska-Zwierz for the invite and all the excellent questions after my talk – was a stimulating and interesting day!
June 20, 2025 at 10:05 AM
Many thanks to Paulina Kolasinska-Zwierz for the invite and all the excellent questions after my talk – was a stimulating and interesting day!
Was great to hear about Alchemab work on resilient individuals and how to identify antibodies with similar properties as novel therapeutics. Also good to discuss the challenges of the blood-brain barrier in the context of drug discovery and development.
June 20, 2025 at 10:04 AM
Was great to hear about Alchemab work on resilient individuals and how to identify antibodies with similar properties as novel therapeutics. Also good to discuss the challenges of the blood-brain barrier in the context of drug discovery and development.
Looking forward to the next meeting in a years’ time and for the ongoing enrichment and differing focus that collaborating with industry gives to a project!
May 22, 2025 at 4:23 PM
Looking forward to the next meeting in a years’ time and for the ongoing enrichment and differing focus that collaborating with industry gives to a project!
There was an excellent range of posters and talks from UCB funded PhD students reflecting the cutting-edge science that is performed with academic collaborators. Also, the application of this research to aid in the R&D process was clear and lead to a vibrate and informative meeting.
May 22, 2025 at 4:23 PM
There was an excellent range of posters and talks from UCB funded PhD students reflecting the cutting-edge science that is performed with academic collaborators. Also, the application of this research to aid in the R&D process was clear and lead to a vibrate and informative meeting.
My lab has extensive expertise in targeted drug delivery to the brain and has established a cutting-edge cellular BBB model for drug and disease modelling. This means we are at the forefront of research into this exciting area of unmet need. news.liverpool.ac.uk/2025/01/22/r...
Revealing insights into neurological disease treatment - University of Liverpool News
Revealing insights into neurological disease treatment
news.liverpool.ac.uk
January 23, 2025 at 9:06 AM
My lab has extensive expertise in targeted drug delivery to the brain and has established a cutting-edge cellular BBB model for drug and disease modelling. This means we are at the forefront of research into this exciting area of unmet need. news.liverpool.ac.uk/2025/01/22/r...
As crossing this barrier is a major stumbling block for the development of new treatments for brain cancers.
December 13, 2024 at 4:16 PM
As crossing this barrier is a major stumbling block for the development of new treatments for brain cancers.